NEW YORK, Jan. 21, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Southwest Airlines Co. (“Southwest” or the “Company”) (NYSE: LUV). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.
The investigation concerns whether Southwest and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On December 26, 2022, Business Insider published an article entitled “US Department of Transportation says it plans to look into Southwest Airlines following the airline’s ‘unacceptable’ holiday flight cancellations.” The article stated, among other things, that the “U.S. DOT tweeted Monday it will examine whether Southwest is abiding by its customer service policy[,]” and “Southwest cancelled nearly 3,000 flights on the day after Christmas, the most of any U.S. airline.”
On this news, Southwest’s stock fell $2.15 per share, or 5%, to close at $33.94 per share on December 27, 2022.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com
888-476-6529 ext. 7980
- SECU Foundation Sponsors Production of PBS North Carolina’s 2023 Year of the Trail Series - March 23, 2023
- Avalyn Pharma Publishes Phase 1b ATLAS Results Demonstrating Stabilization of Lung Function at 24 and 48 Weeks with AP01 and Favorable Safety Profile - March 23, 2023
- Opus EHR Partners with Mindful Health for Improved Operating Efficiency and Patient Engagement - March 23, 2023
